دورية أكاديمية
أعرض في EDS

Traditional Chinese medicine for acute myocardial infarction in Western medicine hospitals in China

التفاصيل البيبلوغرافية
العنوان: Traditional Chinese medicine for acute myocardial infarction in Western medicine hospitals in China
المؤلفون: Spatz, E.S., Wang, Y., Beckman, A.L., Wu, X., Lu, Y., Du, X., Li, J., Xu, X., Davidson, P.M., Masoudi, F.A., Spertus, J.A., Krumholz, H.M., Jiang, L.
المصدر: http://dx.doi.org/10.1161/circoutcomes.117.004190Test.
بيانات النشر: American Heart Association; Wolters Kluwer
سنة النشر: 2018
المجموعة: The University of Adelaide: Digital Library
مصطلحات موضوعية: Cardiovascular diseases, complementary therapies, medicine, Chinese traditional, quality of health care, Salvia miltiorrhiza, Humans, Myocardial Infarction, Hemorrhage, Drugs, Chinese Herbal, Treatment Outcome, Hospital Mortality, Risk Assessment, Risk Factors, Retrospective Studies, Health Status, Time Factors, Aged, Middle Aged, Hospitals, China, Female, Male, Patient Safety, Administration, Intravenous
الوصف: Background: Amid national efforts to improve the quality of care for people with cardiovascular disease in China, the use of traditional Chinese medicine (TCM) is increasing, yet little is known about its use in the early management of acute myocardial infarction (AMI). Methods and Results: We aimed to examine intravenous use of TCM within the first 24 hours of hospitalization (early IV TCM) for AMI. Data come from the China Patient-centered Evaluative Assessment of Cardiac Events Retrospective Study of Acute Myocardial Infarction, restricted to a large, representative sample of Western medicine hospitals throughout China (n=162). We conducted a chart review of randomly sampled patients with AMI in 2001, 2006, and 2011, comparing early intravenous TCM use across years, predictors of any early intravenous TCM use, and association with in-hospital bleeding and mortality. From 2001 to 2011, early intravenous TCM use increased (2001: 38.2% versus 2006: 49.1% versus 2011: 56.1%; P<0.01). Nearly all (99%) hospitals used early intravenous TCM. Salvia miltiorrhiza was most commonly prescribed, used in one third (35.5%) of all patients admitted with AMI. Patients receiving any early intravenous TCM, compared with those who did not, were similar in age and sex and had fewer cardiovascular risk factors. In multivariable hierarchical models, admission to a secondary (versus tertiary) hospital was most strongly associated with early intravenous TCM use (odds ratio: 2.85; 95% confidence interval: 1.98–4.11). Hospital-level factors accounted for 55% of the variance (adjusted median odds ratio: 2.84). In exploratory analyses, there were no significant associations between early intravenous TCM and in-hospital bleeding or mortality. Conclusions: Early intravenous TCM use for AMI in China is increasing despite the lack of evidence of their benefit or harm. There is an urgent need to define the effects of these medications because they have become a staple of treatment in the world’s most populous country. ; Erica S. Spatz, ...
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
تدمد: 1941-7713
1941-7705
العلاقة: Circulation: Cardiovascular Quality and Outcomes, 2018; 11(3):e004190-1-e004190-11; https://hdl.handle.net/2440/132275Test; Spertus, J.A. [0000-0002-2839-2611]
DOI: 10.1161/CIRCOUTCOMES.117.004190
الإتاحة: https://doi.org/10.1161/CIRCOUTCOMES.117.004190Test
https://doi.org/10.1161/circoutcomes.117.004190Test
https://hdl.handle.net/2440/132275Test
حقوق: © 2018 The Authors. Circulation: Cardiovascular Quality and Outcomes is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
رقم الانضمام: edsbas.BC4F121D
قاعدة البيانات: BASE
الوصف
تدمد:19417713
19417705
DOI:10.1161/CIRCOUTCOMES.117.004190